title: Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan.
abstract: Persistent pulmonary hypertension of the newborn (PPHN) occurs in 1-4% of neonates with transposition of the great arteries with intact ventricular septum (TGA/IVS). This association is often lethal. To our knowledge, only eight survivors have been described in the literature, two of whom benefited from extracorporeal membrane oxygenation (ECMO). We report two cases of PPHN complicating a TGA/IVS that were refractory to multiple therapies and resolved 48 hours after initiation of bosentan therapy. Bosentan, an oral dual endothelin-1 receptor antagonist, is a new treatment for pulmonary arterial hypertension that was both effective and safe in these two cases of TGA/IVS with PPHN. To our knowledge, it is the first use of bosentan in newborns.
authors: Médecine néonatale et réanimation pédiatrique polyvalente, Centre Hospitalier Universitaire, Place Victor Pauchet, 80054, Amiens Cedex 1, France. goissen.celine@chu-amiens.fr
authors: C
authors: C
authors: Goissen
authors: L
authors: L
authors: Ghyselen
authors: P
authors: P
authors: Tourneux
authors: G
authors: G
authors: Krim
authors: L
authors: L
authors: Storme
authors: P
authors: P
authors: Bou
authors: Y
authors: Y
authors: Maingourd
mesh_terms: D000284:Administration, Oral; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D000077300:Bosentan; D004452:Echocardiography; D005500:Follow-Up Studies; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007231:Infant, Newborn; D008297:Male; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D013449:Sulfonamides / Q000008:administration & dosage*; D014188:Transposition of Great Vessels / Q000150:complications* / Q000000981:diagnostic imaging / Q000503:physiopathology
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan
references: Circulation. 2000 Jul 25;102(4):411-8
references: 10908213
references: Clin Perinatol. 2001 Sep;28(3):609-27, vii
references: 11570157
references: Am J Physiol. 1998 Apr;274(4 Pt 1):L535-41
references: 9575871
references: Eur J Pediatr. 2001 Apr;160(4):217-22
references: 11317642
references: Clin Pharmacol Ther. 2003 Apr;73(4):372-82
references: 12709727
references: J Clin Invest. 1997 Mar 15;99(6):1179-86
references: 9077525
references: Am J Cardiol. 1974 Jul;34(1):75-82
references: 4835757
references: Pediatrics. 2006 Apr;117(4):1077-83
references: 16585301
references: Ann Thorac Surg. 1996 Mar;61(3):800-5
references: 8619696
references: Pediatr Res. 1996 Mar;39(3):435-42
references: 8929863
references: J Am Coll Cardiol. 2003 Apr 16;41(8):1380-6
references: 12706935
references: Am J Cardiol. 1991 Nov 1;68(11):1253-5
references: 1951094
references: N Engl J Med. 2002 Mar 21;346(12):896-903
references: 11907289
references: J Pediatr. 1993 Jul;123(1):109-14
references: 8320603
references: Acta Paediatr. 2005 Jul;94(7):912-6
references: 16188814
references: Pediatr Res. 1998 Aug;44(2):175-80
references: 9702910
references: J Pediatr. 1997 Apr;130(4):603-11
references: 9108859
references: Ann Thorac Surg. 2005 Jun;79(6):2155-8
references: 15919337